Methylprednisolone Sodium Succinate Injection, Powder, For Solution
Product Images NDC 0143-9851

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Methylprednisolone Sodium Succinate (NDC 0143-9851). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Methylprednisolone Sodium Succinate Chemical Structure (Methylprednisolone Sodium Succinate For Injection 1)

Chemical structure of Methylprednisolone Sodium Succinate depicting its molecular framework with multiple rings, hydroxyl groups, and a sodium succinate ester side chain.*

FDA Label Image

Plb243wes.2 (Methylprednisolone Sodium Succinate For Injection 2)

Label for Methylprednisolone Sodium Succinate injection powder for solution, USP, 1 gram per vial. The vial is lyophilized and intended for intramuscular or intravenous use only. The label specifies it as a multiple dose vial with 8 x 125 mg doses. Manufactured by Hikma Pharmaceuticals USA Inc. Storage and reconstitution instructions are included on the label.*

FDA Label Image

Pbx759-wes.1 (Methylprednisolone Sodium Succinate For Injection 3)

Packaging label for Methylprednisolone Sodium Succinate injection, USP, 1 gram per vial. The label states it is a lyophilized powder for solution, intended for intramuscular or intravenous use only. It is a multiple dose vial manufactured by Hikma Pharmaceuticals USA Inc. The label includes preparation instructions specifying the use of bacteriostatic water for injection with benzyl alcohol as a preservative, but notes this package does not contain the diluent.*

FDA Label Image

Plb244-wes.1 (Methylprednisolone Sodium Succinate For Injection 4)

Label for Methylprednisolone Sodium Succinate Injection, USP 500 mg per vial, a lyophilized powder for injection. The label indicates usage for intramuscular (IM) or intravenous (IV) administration, specifying multiple doses at 125 mg each. It includes storage instructions, reconstitution directions, and manufacturer information for Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Pbx760-wes.1 (Methylprednisolone Sodium Succinate For Injection 5)

Packaging label for Methylprednisolone Sodium Succinate injection, powder for solution, 500 mg per vial. The label indicates it is a lyophilized single-dose vial intended for intramuscular or intravenous use. It includes storage instructions, reconstitution details, and notes that it contains benzyl alcohol as a preservative but not as a diluent. The product is manufactured by Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.